REGN Regeneron Pharmaceuticals (NASDAQ: REGN): Q3 2019 Earnings Snapshot 6 years ago — Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter 2019 adjusted earnings of $6.67 per share versus $6.36 per share… « Previous